News
Why One Fund Bought $8 Million of Viasat Stock and Made It a Top 3 Holding
New York City-based 13D Management disclosed a new position in Viasat (NASDAQ:VSAT) valued at approximately $7.82 million, according to a November 14 Securities and Exchange Commission filing.
Should You Buy Robinhood (HOOD) Stock Before February?
Robinhood's (NASDAQ: HOOD) stock nearly tripled over the past 12 months. The online brokerage dazzled investors with its robust revenue growth, rising margins, and soaring profits.
Does Robinhood's
Rule Breaker Investing: Old, New, Borrowed & Blue, Vol. 10
In this podcast, Motley Fool co-founder David Gardner brings back a few life hacks, peeves, and perks from past episodes; introduces a new financial holiday -- National Share Day -- imagining a
The Best Warren Buffett Stock to Invest $1,000 in Right Now
After six decades at the helm, Warren Buffett will step down as Berkshire Hathaway's (NYSE: BRK.A) (NYSE: BRK.B) CEO at the end of 2025. However, investors will likely continue to track Berkshire's
Yiheng Capital Dumps 270,000 Planet Fitness Shares Worth $29.4 Million
Yiheng Capital Management, L.P, fully exited its put option position in Planet Fitness (NYSE:PLNT) in the quarter ending September 30, 2025, according to a November 14, 2025, SEC filing.
According
SPY vs SPLG: Two Ways to Own the S&P 500
The main distinction between SPDR Portfolio S&P 500 ETF (SPLG) and SPDR S&P 500 ETF Trust (SPY) lies in SPLG’s lower expense ratio, while SPY stands out for its immense scale and trading liquidity.
Want More Retirement Income? 3 Wealth-Boosting Strategies to Look At
There are plenty of good reasons to get excited for retirement to arrive. Not only might it be nice to not have to work every day, but you may have a host of activities you're eager to embark on
Why This Fund Cashed Out of a $3.6 Million Biotech ETF Bet
Kentucky-based Aristides Capital fully exited its position in the iShares Biotechnology ETF (NASDAQ:IBB), reducing its portfolio by approximately $3.60 million, according to a November 13 SEC
The Quantum Computing Stock Big Money Managers Are Quietly Buying
Quantum computing could be the next major technological breakthrough. While many tech giants are developing quantum systems, there are also a few pure-play quantum computing companies -- and one has
Don't Call It a Comeback
In this podcast, Motley Fool contributors Travis Hoium, Jon Quast, and Rachel Warren discuss:
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're
LQD vs VCLT: Stability or Income Opportunity
Vanguard Long-Term Corporate Bond ETF (VCLT) looks more affordable and offers a higher payout than iShares iBoxx Investment Grade Corporate Bond ETF (LQD), but comes with greater risk and a narrower
Why a New $10 Million Fluor Stock Buy Signals Confidence After a Rough Year
Kentucky-based Aristides Capital initiated a new position in Fluor Corporation (NYSE:FLR) during the third quarter, acquiring 224,842 shares in an estimated $9.46 million stake as of September 30.
Protect Your Retirement: Avoid These 3 AI Stocks Right Now
By now, you've probably heard about the artificial intelligence (AI) "spending boom" that's powering the stock market's explosive growth.
The trouble is, while lots of businesses are investing
The Best Dividend Stock to Buy With $50 Right Now
Although it may have "old" in its name, dividend payouts from Old Republic International (NYSE: ORI) consistently reach new highs. Over the past four fiscal quarters, the insurance company has paid
4 Reasons to Buy XRP before 2030
XRP (CRYPTO: XRP), which was launched in 2012, had its earliest trading price of $0.006 per token in Aug. 2013. Today, it trades at about $1.84.
That rally would have turned a $1,000 investment into
If I Could Buy Only 1 "Magnificent Seven" Stock in 2026, This Would Be It
The premise of only picking a single stock from a small group of options obviously doesn't apply in the real world. You can buy any stock (or as many stocks as) you want to at any given time.
Should You Invest in Ozempic Maker Novo Nordisk in 2026?
Is there a more popular health trend right now than GLP-1 agonist obesity drugs such as Ozempic? Probably not. Ironically, though, investing in Ozempic, or rather in its manufacturer, Novo Nordisk
Billionaire Family Office Dumps All of Its UroGen Stock Amid 100% Rally
New York City-based Wildcat Capital Management sold out its entire position in UroGen Pharma Ltd. (NASDAQ:URGN), a move representing a net position change of approximately $6.79 million, according
2 Incredibly Popular Stocks to Sell Before They Plummet 54% to 74% in 2026, According to Select Wall Street Analysts
The S&P 500 (SNPINDEX: ^GSPC) is set to close out 2025 on a high note. The widely followed stock index sits near its all-time high after a strong bull run that's lasted over three years. Technology
What a Billionaire Family Office's $16.6 Million Exit From TIC Solutions Signals for Long-Term Investors
New York City-based Wildcat Capital Management sold out its position in TIC Solutions, Inc. (NYSE:TIC) during the third quarter, reducing exposure by 1.5 million shares with a net change of $16.56
Ed Yardeni Steps Back From the "Magnificent Seven" and Bets on the Impressive 493 Instead
After being long big tech in the broader benchmark S&P 500 index for the past 15 years, Ed Yardeni of Yardeni Research is now shifting his stance on the group, which includes the "Magnificent
Sirius XM Is Down 9% in 2025. Is This a Once-in-a-Lifetime Buying Opportunity Before the Stock Goes Parabolic?
The U.S. stock market is on track to close out 2025 with another double-digit percentage return. But not every company contributed positively to that result. For example, as of Friday morning,
3 Reasons to Buy Target Stock Like There's No Tomorrow
Target (NYSE: TGT) is one of the largest retailers in the United States. It is a Dividend King and has a lofty 4.7% dividend yield. If you have a contrarian bent, you might want to buy this
What a $14 Million Accelerant Bet Signals to Long-Term Investors After the Firm's July IPO
Utah-based Grandeur Peak Global Advisors initiated a new position in Accelerant Holdings (NYSE:ARX), acquiring 945,929 shares valued at $14.08 million, according to a November 13 SEC filing.
Why a $30 Million Bruker Stock Trim Matters Amid an 18% Slide
Utah-based Grandeur Peak Global Advisors reduced its stake in Bruker Corporation (NASDAQ:BRKR) by 709,697 shares in the third quarter, contributing to a net position change of $29.54 million


